NeuroScience | Kavinace Flash-Ease | 30 Capsules

NeuroScience

$ 56.00 

Kavinace Flash-Ease | 30 Capsules:

Dietary Supplement!

Contains ingredients shown to improve sleep and reduce vasomotor symptoms*

  • GABA is the primary inhibitory neurotransmitter in the brain, which means it plays a central role in balancing the excitability of neurons (1). Because of this reason, GABA is important for promoting sleep, calm, and managing stress (2-4). Stress is thought to alter GABA synthesis and activity by affecting the expression of GABA-synthesizing enzymes and receptors (5).
  • Serotonin is important for modifying the thermoregulatory set point (6). This means supporting serotonin may help to ameliorate hot flashes (7). Kavinace Flash-Ease contains 5-HTP (precursor to serotonin) and two botanicals with serotonergic activity (ashwagandha and black cohosh) (8,9).* Ashwagandha supports a healthy stress response, while black cohosh exhibits GABAergic and potentially selective estrogenic activity (8,10,11).* In a randomized, double-blind, placebo-controlled study, black cohosh significantly reduced vasomotor symptoms, improved sleep quality, and reduced wakefulness after falling asleep (12).*

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Supplement Facts:

Serving Size: 1 Capsule
Servings Per Container: 30

Amount Per Serving:

Ingredient Amount % Daily Value
Proprietary Blend
4-amino-3-phenylbutyric acid HCI,
Ashwagandha root extract,
5-hydroxytryptophan (from Griffonia 
simplicfolia seed extract), Black cohosh root 
extract (standardized to 2.5% triterpene
glycosides)
550 mg

†Daily Value not established.

Suggested Use:

Take 1 capsule at bedtime as needed or as directed by your healthcare provider.

Other Ingredients:

Microcrystalline cellulose, Vegetable capsule (Hypromellose, water), and Magnesium stearate (vegetable source).

Notes/Warnings:

If you are pregnant or nursing, consult your healthcare provider before use.

References:

  1. Gou Z, et al. Dongwuxue Yanjiu. 2012;33(E5-6):E75-81.
  2. Mohler H. Neuropharmacology. 2012;62(1):42-53.
  3. Saper C, et al. Nature. 2005;437(7063):1257-63.
  4. Mody I and Maguire J. Front Cell Neurosci. 2012;6:4.
  5. Maguire J. Front Cell Neurosci. 2014;8:157.
  6. Bruck K and Zeisberger E. Pharmacol Ther. 1987;35(1-2):163-215.
  7. Freedman R. et al. Menopause. 2011;18(8):893-6.
  8. Wuttke W, et al. J Steroid Biochem Mol Biol. 2014;139:302-10.
  9. Kaurav B, et al. Asian Pac J Trop Med. 2012;5(5):380-4.
  10. Auddy B, et al. J Am Neutraceut Assoc. 2008;11:50-56.
  11. Jarry H, et al. Maturitas. 2003;44 Suppl 1:S31-8.
  12. Jiang K, et al. Climacteric. 2015;18(4):559-67.